Low testosterone and anaemia in men with type 2 diabetes

Clinical Endocrinology

Volumn 70, Issue 4, 2009, Pages 547-553

  Grossmann, Mathis ^a   Panagiotopolous, Sianna ^a   Sharpe, Ken ^a   MacIsaac, Richard J ^a   Clarke, Sophie ^a   Zajac, Jeffrey D ^a   Jerums, George ^a   Thomas, Merlin C ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; C REACTIVE PROTEIN; ERYTHROPOIETIN; HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; ANDROGEN DEFICIENCY; ANEMIA; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANEMIA; C-REACTIVE PROTEIN; CHRONIC DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ERYTHROPOIETIN; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; TESTOSTERONE;

EID: 61449237409     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03357.x     Document Type: Article

References (35)

1. Thomas, M.C., MacIsaac, R.J., Tsalamandris, C. et al. (2003) Unrecognized anemia in patients with diabetes: a cross-sectional survey. Diabetes Care, 26, 1164 1169.
2. Thomas, M.C. (2007) Anemia in diabetes: marker or mediator of microvascular disease? Nature Clinical Practice. Nephrology, 3, 20 30.
3. Astor, B.C., Muntner, P., Levin, A. et al. (2002) Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-94). Archives of Internal Medicine, 162, 1401 1408.
4. Dhindsa, S., Prabhakar, S., Sethi, M. et al. (2004) Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 89, 5462 5468.
5. Grossmann, M., Thomas, M.C., Panagiotopoulos, S. et al. (2008) Low Testosterone Levels are Common and Associated with Insulin Resistance in Men with Diabetes. Journal of Clinical Endocrinology and Metabolism, 93, 1834 1840.
6. Barrett-Connor, E., Khaw, K.T. Yen, S.S. (1990) Endogenous sex hormone levels in older adult men with diabetes mellitus. American Journal of Epidemiology, 132, 895 901.
7. Shahidi, N.T. (1973) Androgens and erythropoiesis. New England Journal of Medicine, 289, 72 80.
8. Sikaris, K., McLachlan, R.I., Kazlauskas, R. et al. (2005) Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. Journal of Clinical Endocrinology and Metabolism, 90, 5928 5936.
9. Dunn, J.F., Nisula, B.C. Rodbard, D. (1981) Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. Journal of Clinical Endocrinology and Metabolism, 53, 58 68.
10. Rosner, W., Auchus, R.J., Azziz, R. et al. (2007) Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism, 92, 405 413.
11. Vermeulen, A., Verdonck, L. Kaufman, J.M. (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism, 84, 3666 3672.
12. Vermeulen, A. (2005) Hormonal cut-offs of partial androgen deficiency: a survey of androgen assays. Journal of Endocrinological Investigation, 28, 28 31.
13. Beutler, E. Waalen, J. (2006) The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood, 107, 1747 1750.
14. Thomas, M.C., Tsalamandris, C., Macisaac, R. et al. (2006) Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia. Diabetic Medicine, 23, 502 509.
15. Owen, W.E. Roberts, W.L. (2004) Performance characteristics of the IMMUNLITE 2000 erythropoietin assay. Clinical Chimica Acta, 340, 213 217.
16. Macisaac, R.J., Tsalamandris, C., Thomas, M.C. et al. (2006) Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia, 49, 1686 1689.
17. (2007) KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. American Journal of Kidney Diseases, 49, S12 S154.
18. Ferrucci, L., Maggio, M., Bandinelli, S. et al. (2006) Low testosterone levels and the risk of anemia in older men and women. Archives of Internal Medicine, 166, 1380 1388.
19. Bhatia, V., Chaudhuri, A., Tomar, R. et al. (2006) Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care, 29, 2289 2294.
20. Fonseca, R., Rajkumar, S.V., White, W.L. et al. (1998) Anemia after orchiectomy. American Journal of Hematology, 59, 230 233.
21. Strum, S.B., McDermed, J.E., Scholz, M.C. et al. (1997) Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade. British Journal of Urology, 79, 933 941.
22. Thorn, L.M., Forsblom, C., Fagerudd, J. et al. (2005) Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care, 28, 2019 2024.
23. Stehouwer, C.D., Fischer, H.R., van Kuijk, A.W. et al. (1995) Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes, 44, 561 564.
24. Thomas, M.C., Tsalamandris, C., MacIsaac, R. et al. (2004) Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes. Kidney International, 66, 1167 1172.
25. Kapoor, D., Clarke, S., Stanworth, R. et al. (2007) The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. European Journal of Endocrinology, 156, 595 602.
26. Snyder, P.J., Peachey, H., Berlin, J.A. et al. (2000) Effects of testosterone replacement in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 85, 2670 2677.
27. Bhasin, S., Cunningham, G.R., Hayes, F.J. et al. (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 91, 1995 2010.
28. Kapoor, D., Aldred, H., Clark, S. et al. (2007) Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care, 30, 911 917.
29. Kapoor, D., Goodwin, E., Channer, K.S. et al. (2006) Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. European Journal of Endocrinology, 154, 899 906.
30. Rhoden, E.L. Morgentaler, A. (2004) Risks of testosterone-replacement therapy and recommendations for monitoring. New England Journal of Medicine, 350, 482 492.
31. Singh, A.K., Szczech, L., Tang, K.L. et al. (2006) Correction of anemia with epoetin alfa in chronic kidney disease. New England Journal of Medicine, 355, 2085 2098.
32. Drueke, T.B., Locatelli, F., Clyne, N. et al. (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. New England Journal of Medicine, 355, 2071 2084.
33. Zhu, X. Perazella, M.A. (2006) Nonhematologic complications of erythropoietin therapy. Seminars in Dialysis, 19, 279 284.
34. Besarab, A., Bolton, W.K., Browne, J.K. et al. (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. New England Journal of Medicine, 339, 584 590.
35. Thomas, M.C., Cooper, M.E., Rossing, K. et al. (2006) Anaemia in diabetes: is there a rationale to TREAT? Diabetologia, 49, 1151 1157.